Genpact Ltd. Files 8-K for Material Agreement
Ticker: G · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1398659
Sentiment: neutral
Topics: material-agreement, financial-obligation
Related Tickers: G
TL;DR
Genpact signed a big deal, expect financial moves.
AI Summary
On November 18, 2025, Genpact Limited entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. The report includes financial statements and exhibits related to these events.
Why It Matters
This 8-K filing signals a significant new agreement for Genpact Ltd., potentially impacting its financial obligations and future operations.
Risk Assessment
Risk Level: medium — Material definitive agreements and new financial obligations can introduce new risks and opportunities that may affect the company's financial health.
Key Players & Entities
- Genpact Limited (company) — Registrant
- November 18, 2025 (date) — Date of earliest event reported
FAQ
What type of material definitive agreement did Genpact Limited enter into?
The filing indicates the entry into a material definitive agreement but does not specify the exact nature of the agreement in the provided text.
What is the nature of the financial obligation created by Genpact Limited?
The filing states the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specifics are not detailed in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on November 18, 2025.
What is Genpact Limited's principal executive office address?
Genpact Limited's principal executive offices are located at Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda.
What is the Commission File Number for Genpact Limited?
The Commission File Number for Genpact Limited is 001-33626.
Filing Stats: 1,690 words · 7 min read · ~6 pages · Grade level 11.6 · Accepted 2025-11-18 16:16:08
Key Financial Figures
- $0.01 — ch registered Common shares, par value $0.01 per share G New York Stock Exchange
- $350 million — blic offering (the "Notes Offering") of $350 million aggregate principal amount of their 4.9
Filing Documents
- ny20058398x8_8k.htm (8-K) — 43KB
- ny20058398x8_ex1-1.htm (EX-1.1) — 208KB
- ny20058398x8_ex4-1.htm (EX-4.1) — 525KB
- ny20058398x8_ex4-2.htm (EX-4.2) — 145KB
- ny20058398x8_ex4-4.htm (EX-4.4) — 27KB
- ny20058398x8_ex5-1.htm (EX-5.1) — 14KB
- ny20058398x8_ex5-2.htm (EX-5.2) — 66KB
- ny20058398x8_ex5-3.htm (EX-5.3) — 51KB
- ny20058398x8_ex5-4.htm (EX-5.4) — 70KB
- ny20058398x8_ex5-1img001.jpg (GRAPHIC) — 3KB
- ny20058398x8_ex5-1img002.jpg (GRAPHIC) — 83KB
- ny20058398x8_ex5-2img001.jpg (GRAPHIC) — 3KB
- ny20058398x8_ex5-4img001.jpg (GRAPHIC) — 2KB
- 0001140361-25-042599.txt ( ) — 1640KB
- g-20251118.xsd (EX-101.SCH) — 4KB
- g-20251118_lab.xml (EX-101.LAB) — 21KB
- g-20251118_pre.xml (EX-101.PRE) — 16KB
- ny20058398x8_8k_htm.xml (XML) — 4KB
01
Item 1.01. Entry into a Material Definitive Agreement. Notes Offering On November 18, 2025, Genpact UK Finco plc ("Genpact UK") and Genpact USA, Inc. ("Genpact USA"), indirect wholly owned subsidiaries of Genpact Limited ("Genpact"), completed their previously announced underwritten public offering (the "Notes Offering") of $350 million aggregate principal amount of their 4.950% Senior Notes due 2030 (the "2030 Notes"). The 2030 Notes are Genpact UK's and Genpact USA's senior unsecured indebtedness and are guaranteed on a senior unsecured basis by Genpact and Genpact Luxembourg S. r.l. ("Genpact Luxembourg"). The 2030 Notes were issued pursuant to an indenture dated as of November 18, 2025 (the "Base Indenture") among Genpact UK, Genpact USA, Genpact, Genpact Luxembourg and Computershare Trust Company, National Association, as trustee (the "Trustee"), and a first supplemental indenture dated as of November 18, 2025 (the "First Supplemental Indenture"). The 2030 Notes have been registered under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to an effective shelf registration statement on Form S-3 (File No. 333-291491), as supplemented by the prospectus supplement dated November 13, 2025, filed with the Securities and Exchange Commission under the Securities Act. In connection with the issuance of the 2030 Notes, Genpact, Genpact UK, Genpact USA and Genpact Luxembourg entered into an Underwriting Agreement dated as of November 13, 2025 (the "Underwriting Agreement"), among Genpact UK and Genpact USA, as co-issuers, Genpact and Genpact Luxembourg, as guarantors, and the representatives of the several underwriters named therein (the "Underwriters"), pursuant to which Genpact UK and Genpact USA agreed to issue and sell the 2030 Notes to the Underwriters. For a complete description of the terms and conditions of the Underwriting Agreement, please refer to the Underwriting Agreement, which is filed as Exhibit 1.1 hereto, and is incorporated he
03
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained in Item 1.01 is incorporated by reference in this Item 2.03.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits The following exhibits are filed with this Current Report on Form 8-K: Exhibit No. Description 1.1* Underwriting Agreement, dated as of November 13, 2025, among Genpact UK and Genpact USA, as co-issuers, Genpact and Genpact Luxembourg, as guarantors, and Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the Underwriters. 4.1 Indenture, dated as of November 18, 2025, by and among Genpact UK, Genpact USA, Genpact, Genpact Luxembourg and Computershare Trust Company, National Association, as trustee. 4.2 First Supplemental Indenture, dated as of November 18, 2025, by and among Genpact UK, Genpact USA, Genpact and Genpact Luxembourg and Computershare Trust Company, National Association, as trustee. 4.3 Form of 4.950% Senior Note due 2030 (included as Exhibit A to the First Supplemental Indenture filed as Exhibit 4.2). 4.4 Third Supplemental Indenture, dated as of November 18, 2025, by and among Genpact Luxembourg, Genpact USA, Genpact, Genpact UK and Computershare Trust Company, National Association (as successor to Wells Fargo Bank, National Association), as trustee. 5.1 Opinion of Cravath, Swaine & Moore LLP. 5.2 Opinion of Allen Overy Shearman Sterling SCS socit en commandite simple (inscrite au barreau de Luxembourg). 5.3 Opinion of Appleby (Bermuda) Limited. 5.4 Opinion of Slaughter and May. 23.1 Consent of Cravath, Swaine & Moore LLP (included in Exhibit 5.1). 23.2 Consent of Allen Overy Shearman Sterling SCS socit en commandite simple (inscrite au barreau de Luxembourg) (included in Exhibit 5.2). 23.3 Consent of Appleby (Bermuda) Limited (included in Exhibit 5.3). 23.4 Consent of Slaughter and May (included in Exhibit 5.4). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Schedules or similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Genpact